SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-030940
Filing Date
2023-11-08
Accepted
2023-11-08 16:08:00
Documents
14
Period of Report
2023-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bcda20231107_8k.htm   iXBRL 8-K 27157
2 EXHIBIT 99.1 ex_593478.htm EX-99.1 91344
  Complete submission text file 0001437749-23-030940.txt   279529

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bcda-20231108.xsd EX-101.SCH 3873
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20231108_def.xml EX-101.DEF 13416
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20231108_lab.xml EX-101.LAB 17616
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20231108_pre.xml EX-101.PRE 13393
8 EXTRACTED XBRL INSTANCE DOCUMENT bcda20231107_8k_htm.xml XML 4323
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38999 | Film No.: 231387858
SIC: 2836 Biological Products, (No Diagnostic Substances)